Genetic matters: Thirty years of progress using mouse models in nicotinic research

Biochemical Pharmacology

Volumn 86, Issue 8, 2013, Pages 1105-1113

  Marks, Michael J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Knockout mice; Mouse genetics; Mutations; Nicotine; Nicotinic acetylcholine receptors

Indexed keywords

EID: 84885646416     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.05.021     Document Type: Review

References (100)

1. Fisher RA. Cancer and smoking. Nature 1958;182:596.
2. Uhl GR, Drgon T, Johnson C, Li CY, Contoreggi C, Hess J, et al. Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify connectivity constellation and drug target genes with pleiotropic effects. Ann N Y Acad Sci 2008;1141:318-81.
3. Vrieze SI, McGue M, Iacono WG. The interplay of genes and adolescent development in substance use disorders: leveraging findings from GWAS meta-Analyses to test developmental hypotheses about nicotine consumption. Hum Genet 2012;131:791-801.
4. Hopfer CJ, Crowley TJ, Hewitt JK. Review of twin and adoption studies of adolescent substance use. J Am Acad Child Adolesc Psychiatry 2003;42:710-9. (Pubitemid 39625057)
5. Tyndale RF. Genetics of alcohol and tobacco use in humans. Ann Med 2003;35:94-121. (Pubitemid 36638212)
6. Li MD, Cheng R, Ma JZ, Swan GE. A meta-Analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003;98:23-31. (Pubitemid 36044333)
7. Marks MJ, Burch JB, Collins AC. Genetics of nicotine response in four inbred strains of mice. J Pharmacol Exp Ther 1983;226:291-302. (Pubitemid 13026216)
8. Marks MJ, Miner L, Burch JB, Fulker DW, Collins AC. A diallel analysis of nicotine-induced hypothermia. Pharmacol Biochem Behav 1984;21:953-9. (Pubitemid 15150750)
9. Marks MJ, Miner LL, Cole-Harding S, Burch JB, Collins AC. A genetic analysis of nicotine effects on open field activity. Pharmacol Biochem Behav 1986;24:743-9. (Pubitemid 16145219)
10. Marks MJ, Stitzel JA, Collins AC. Genetic influences on nicotine responses. Pharmacol Biochem Behav 1989;33:667-78. (Pubitemid 19237546)
11. Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, Le Novere N, et al. Abnormal avoidance learning in mice lacking functional high-Affinity nicotine receptor in the brain. Nature 1995;374:65-7.
12. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Lena C, Le Novere N, de Kerchove d'Exaerde A, et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 1999;398:805-10.
13. Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, Berg DK, et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 1999;51:397-401. (Pubitemid 29269984)
14. Orr-Urtreger A, Goldner FM, Saeki M, Lorenzo I, Goldberg L, De Biasi M, et al. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 1997;17:9165-71. (Pubitemid 27498444)
15. Marks MJ, Romm E, Campbell SM, Collins AC. Variation of nicotinic binding sites among inbred strains. Pharmacol Biochem Behav 1989;33:679-89. (Pubitemid 19237547)
16. TammimakiA,HortonWJ, Stitzel JA. Recent advances in genemanipulation and nicotinic acetylcholine receptor biology. BiochemPharmacol 2011;82:808-19.
17. Tritto T, McCallum SE, Waddle SA, Hutton SR, Paylor R, Collins AC, et al. Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine Tob Res 2004;6:145-58.
18. O'Neill HC, Laverty DC, Patzlaff NE, Cohen BN, Fonck C, McKinney S, et al. Mice expressing the ADNFLE valine 287 leucine mutation of the Beta2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function. Pharmacol Biochem Behav 2013;103:603-21.
19. Dobelis P, Marks MJ, Whiteaker P, Balogh SA, Collins AC, Stitzel JA. A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function. Mol Pharmacol 2002;62:334-42. (Pubitemid 34804114)
20. De Fiebre CM, Medhurst LJ, Collins AC. Nicotine response and nicotinic receptors in long-sleep and short-sleep mice. Alcohol 1987;4:493-501. (Pubitemid 17163843)
21. Tritto T, Stitzel JA, Marks MJ, Romm E, Collins AC. Variability in response to nicotine in the LSxSS RI strains: potential role of polymorphisms in alpha4 and alpha6 nicotinic receptor genes. Pharmacogenetics 2002;12:197-208. (Pubitemid 34596784)
22. Nelson ME, Kuryatov A, Choi CH, Zhou Y, Lindstrom J. Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Mol Pharmacol 2003;63:332-41. (Pubitemid 36158368)
23. Zhou Y, Nelson ME, Kuryatov A, Choi C, Cooper J, Lindstrom J. Human alpha4beta2 acetylcholine receptors formed from linked subunits. J Neurosci 2003;23:9004-15. (Pubitemid 37243801)
24. Zwart R, Vijverberg HP. Four pharmacologically distinct subtypes of alpha4-beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol Pharmacol 1998;54:1124-31. (Pubitemid 29002058)
25. Moroni M, Zwart R, Sher E, Cassels BK, Bermudez I. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-Term exposure to nicotine. Mol Pharmacol 2006;70:755-68. (Pubitemid 44092336)
26. Marks MJ,Whiteaker P, Calcaterra J, Stitzel JA, Bullock AE, Grady SR, et al. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. J Pharmacol Exp Ther 1999;289:1090-103. (Pubitemid 29191271)
27. Gotti C, Moretti M, Meinerz NM, Clementi F, Gaimarri A, Collins AC, et al. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits. Mol Pharmacol 2008;73:1796-807. (Pubitemid 351724367)
28. Kim H, Flanagin BA, Qin C, Macdonald RL, Stitzel JA. The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs. Neuropharmacology 2003;45:345-54. (Pubitemid 36836131)
29. Briggs CA, Gubbins EJ, Marks MJ, Putman CB, Thimmapaya R, Meyer MD, et al. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors. Mol Pharmacol 2006;70:227-40.
30. Damaj MI, Fonck C, Marks MJ, Deshpande P, Labarca C, Lester HA, et al. Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice. J Pharmacol Exp Ther 2007;321:1161-9. (Pubitemid 46762713)
31. Wang F, Gerzanich V, Wells GB, Anand R, Peng X, Keyser K, et al. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem 1996;271:17656-65. (Pubitemid 26250735)
32. Gerzanich V, Wang F, Kuryatov A, Lindstrom J. alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors. J Pharmacol Exp Ther 1998;286:311-20. (Pubitemid 28318005)
33. Kuryatov A, Onksen J, Lindstrom J. Roles of accessory subunits in alpha4-beta2(*) nicotinic receptors. Mol Pharmacol 2008;74:132-43. (Pubitemid 351872165)
34. Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA, et al. Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther 2010;334:137-46.
35. Ross SA, Wong JY, Clifford JJ, Kinsella A, Massalas JS, Horne MK, et al. Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 2000;20:6431-41.
36. Fowler CD, Kenny PJ. Intravenous nicotine self-Administration and cueinduced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training. Neuropharmacology 2011;61:687-98.
37. Robinson SF, Marks MJ, Collins AC. Inbred mouse strains vary in oral selfselection of nicotine. Psychopharmacology (Berl) 1996;124:332-9. (Pubitemid 26147147)
38. Miner LL, Collins AC. Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol Biochem Behav 1989;33:469-75. (Pubitemid 19245538)
39. Jackson KJ, Walters CL, Miles MF, Martin BR, Damaj MI. Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice. Neuropharmacology 2009;57:347-55.
40. Walters CL, Brown S, Changeux JP, Martin B, Damaj MI. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 2006;184:339-44. (Pubitemid 43255850)
41. McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK. {alpha}4{-beta}2 Nicotinic Acetylcholine Receptors on Dopaminergic Neurons Mediate Nicotine Reward and Anxiety Relief. J Neurosci 2011;31:10891-902.
42. Cahir E, Pillidge K, Drago J, Lawrence AJ. The necessity of alpha4 nicotinic receptors in nicotine-driven behaviors: dissociation between reinforcing and motor effects of nicotine. Neuropsychopharmacology 2011;36:1505-17.
43. Wilking JA, Hesterberg KG, Crouch EL, Homanics GE, Stitzel JA. Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity. Pharmacogenet Genomics 2010;20:121-30.
44. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011;471:597-601.
45. Jackson KJ, McIntosh JM, Brunzell DH, Sanjakdar SS, Damaj MI. The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. J Pharmacol Exp Ther 2009;331:547-54.
46. Miner LL, Marks MJ, Collins AC. Relationship between nicotine-induced seizures and hippocampal nicotinic receptors. Life Sci 1985;37:75-83. (Pubitemid 15039763)
47. Miner LL, Marks MJ, Collins AC. Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse. J Pharmacol Exp Ther 1986;239:853-60. (Pubitemid 17225859)
48. Stitzel JA, Blanchette JM, Collins AC. Sensitivity to the seizure-inducing effects of nicotine is associated with strain-specific variants of the alpha 5 and alpha 7 nicotinic receptor subunit genes. J Pharmacol Exp Ther 1998;284:1104-11. (Pubitemid 28130840)
49. Franceschini D, Paylor R, Broide R, Salas R, Bassetto L, Gotti C, et al. Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures. Brain Res Mol Brain Res 2002;98:29-40. (Pubitemid 34142276)
50. Broide RS, Salas R, Ji D, Paylor R, Patrick JW, Dani JA, et al. Increased sensitivity to nicotine-induced seizures in mice expressing the L250T alpha 7 nicotinic acetylcholine receptor mutation. Mol Pharmacol 2002;61:695-705. (Pubitemid 34171936)
51. Fonck C, Nashmi R, Deshpande P, Damaj MI, Marks MJ, Riedel A, et al. Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors. J Neurosci 2003;23:2582-90. (Pubitemid 36418592)
52. Teper Y, Whyte D, Cahir E, Lester HA, Grady SR, Marks MJ, et al. Nicotineinduced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation. J Neurosci 2007;27:10128-42.
53. Xu J, Cohen BN, Zhu Y, Dziewczapolski G, Panda S, Lester HA, et al. Altered activity-rest patterns in mice with a human autosomal-dominant nocturnal frontal lobe epilepsy mutation in the beta2 nicotinic receptor. Mol Psychiatry 2011;16:1048-61.
54. Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R, De Biasi M. The nicotinic acetylcholine receptor subunit alpha 5 mediates short-Term effects of nicotine in vivo. Mol Pharmacol 2003;63:1059-66. (Pubitemid 36529924)
55. Salas R, Cook KD, Bassetto L, De Biasi M. The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 2004;47:401-7. (Pubitemid 38953231)
56. Luntz-Leybman V, Bickford PC, Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 1992;587:130-6.
57. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ, et al. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 1996;15:152-62. (Pubitemid 26255162)
58. Adams CE, Yonchek JC, Zheng L, Collins AC, Stevens KE. Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. Brain Res 2008;1194:138-45.
59. Stevens KE, Kem WR, Mahnir VM, Freedman R. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl) 1998;136:320-7.
60. Schwartz RD, Kellar KJ. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 1983;220:214-6. (Pubitemid 13115272)
61. Marks MJ, Burch JB, Collins AC. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 1983;226:817-25. (Pubitemid 13007732)
62. Benwell ME, Balfour DJ, Anderson JM. Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J Neurochem 1988;50:1243-7.
63. Breese CR, Marks MJ, Logel J, Adams CE, Sullivan B, Collins AC, et al. Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 1997;282:7-13. (Pubitemid 27425521)
64. Perry DC, Davila-Garcia MI, Stockmeier CA, Kellar KJ. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 1999;289:1545-52. (Pubitemid 29246689)
65. Marks MJ, Romm E, Gaffney DK, Collins AC. Nicotine-induced tolerance and receptor changes in four mouse strains. J Pharmacol Exp Ther 1986;237: 809-19. (Pubitemid 16088097)
66. Marks MJ, Stitzel JA, Collins AC. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains. J Pharmacol Exp Ther 1986;239:358-64. (Pubitemid 17183157)
67. Marks MJ, Campbell SM, Romm E, Collins AC. Genotype influences the development of tolerance to nicotine in the mouse. J Pharmacol Exp Ther 1991;259:392-402.
68. Stoker AK, Markou A. Unraveling the neurobiology of nicotine dependence using genetically engineered mice. Curr Opin Neurobiol 2013. http://dx.doi.org/10.1016/j.conb.2013.02.013 [Epub ahead of print].
69. Fowler CD, Arends MA, Kenny PJ. Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol 2008;19:461-84.
70. Fowler CD, Kenny PJ. Utility of genetically modified mice for understanding the neurobiology of substance use disorders. Hum Genet 2012;131:941-57.
71. Bierut LJ. Genetic vulnerability and susceptibility to substance dependence. Neuron 2011;69:618-27.
72. Schlaepfer IR, Hoft NR, Ehringer MA. The genetic components of alcohol and nicotine co-Addiction: from genes to behavior. Curr Drug Abuse Rev 2008;1:124-34.
73. Portugal GS, Gould TJ. Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Behav Brain Res 2008;193:1-16.
74. Pianezza ML, Sellers EM, Tyndale RF. Nicotine metabolism defect reduces smoking. Nature 1998;393:750. (Pubitemid 28299478)
75. Mann EO, Mody I. The multifaceted role of inhibition in epilepsy: seizuregenesis through excessive GABAergic inhibition in autosomal dominant nocturnal frontal lobe epilepsy. Curr Opin Neurol 2008;21:155-60. (Pubitemid 351644156)
76. Ferini-Strambi L, Sansoni V, Combi R. Nocturnal frontal lobe epilepsy and the acetylcholine receptor. Neurologist 2012;18:343-9.
77. Steinlein OK, Bertrand D. Nicotinic receptor channelopathies and epilepsy. Pflugers Arch 2010;460:495-503.
78. Steinlein OK. Animal models for autosomal dominant frontal lobe epilepsy: on the origin of seizures. Expert Rev Neurother 2010;10:1859-67.
79. Tapper AR, McKinney SL, Marks MJ, Lester HA. Nicotine responses in hypersensitive and knockout alpha 4 mice account for tolerance to both hypothermia and locomotor suppression in wild-Type mice. Physiol Genomics 2007; 31:422-8. (Pubitemid 350127782)
80. Lester HA, Fonck C, Tapper AR, McKinney S, Damaj MI, Balogh S, et al. Hypersensitive knockin mouse strains identify receptors and pathways for nicotine action. Curr Opin Drug Discov Dev 2003;6:633-9. (Pubitemid 37287932)
81. Fonck C, Cohen BN, Nashmi R,Whiteaker P, Wagenaar DA, Rodrigues-Pinguet N, et al. Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4 nicotinic receptors. J Neurosci 2005;25: 11396-411. (Pubitemid 43083712)
82. Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML, et al. Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet 2009;150B:453-66.
83. Bierut LJ. Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25. Trends Pharmacol Sci 2010;31:46-51.
84. Merritt LL, Martin BR, Walters C, Lichtman AH, Damaj MI. The endogenous cannabinoid system modulates nicotine reward and dependence. J Pharmacol Exp Ther 2008;326:483-92.
85. Castane A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 2002;43:857-67.
86. Wang LP, Li F, Shen X, Tsien JZ. Conditional knockout of NMDA receptors in dopamine neurons prevents nicotine-conditioned place preference. PLoS ONE 2010;5:e8616.
87. Berrendero F, Mendizabal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A, et al. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 2005;25:1103-12. (Pubitemid 40268951)
88. Berrendero F, Plaza-Zabala A, Galeote L, Flores A, Bura SA, Kieffer BL, et al. Influence of delta-opioid receptors in the behavioral effects of nicotine. Neuropsychopharmacology 2012;37:2332-44.
89. Neugebauer NM, Henehan RM, Hales CA, Picciotto MR. Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference. Pharmacol Biochem Behav 2011;98:87-93.
90. Lee AM, Messing RO. Protein kinase C epsilon modulates nicotine consumption and dopamine reward signals in the nucleus accumbens. Proc Natl Acad Sci U S A 2011;108:16080-85.
91. Brunzell DH, Mineur YS, Neve RL, Picciotto MR. Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference. Neuropsychopharmacology 2009;34:1993-2001.
92. Wonnacott S, Barik J, Dickinson J, Jones IW. Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters. J Mol Neurosci 2006;30:137-40. (Pubitemid 46035352)
93. Barik J, Wonnacott S. Molecular and cellular mechanisms of action of nicotine in the CNS. Handb Exp Pharmacol 2009;173-207.
94. Pauly JR, Ullman EA, Collins AC. Adrenocortical hormone regulation of nicotine sensitivity in mice. Physiol Behav 1988;44:109-16.
95. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, et al. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 1989;284:314-35. (Pubitemid 19185398)
96. Boulter J, Connolly J, Deneris E, Goldman D, Heinemann S, Patrick J. Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc Natl Acad Sci U S A 1987;84: 7763-7.
97. Marubio LM, Changeux J. Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function. Eur J Pharmacol 2000;393: 113-21. (Pubitemid 30193407)
98. Boulter J, O'Shea-Greenfield A, Duvoisin RM, Connolly JG, Wada E, Jensen A, et al. Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J Biol Chem 1990;265:4472-82.
99. Seguela P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 1993;13:596-604. (Pubitemid 23045143)
100. le Novere N, Zoli M, Lena C, Ferrari R, Picciotto MR, Merlo-Pich E, et al. Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion. Neuroreport 1999;10:2497-501. (Pubitemid 29418126)